Frontiers in neurology

Front Neurol · ISSN (print) 1664-2295 · 31 papers in corpus
2020
doi:10.3389/fneur.2020.549038 ·PMID:33192977

Migraine is a common neurovascular disorder affecting ~15% of the general population. Ranking second in the list of years lived with disability (YLD), people living with migraine are greatly impacted by this especially burdensome primary he…

other 2020
doi:10.3389/fneur.2020.575130 ·PMID:33178117

Introduction: Fibromyalgia (FM) is a frequent comorbidity in patients with chronic migraine (CM). PREEMPT trials, which demonstrated the efficacy of OnabotulinumtoxinA (OnabotA) on CM, excluded patients with FM. Our aim was to evaluate the …

2019
doi:10.3389/fneur.2019.01071 ·PMID:31681146

Introduction: Recent evidence demonstrates that women with myotonic dystrophy type 1 are at increased risk of reproductive organ tumors. However, studies of reproductive cancer risk factors in those patients are lacking. Methods: Using ques…

2019
doi:10.3389/fneur.2019.01170 ·PMID:31824394

Introduction: The aim of this project was to assess the prevalence of four selected SNPs rs4977574 and rs7857345 (CDKN2B-AS1 gene) and rs3798220 and rs10455872 polymorphisms (the LPA gene) in the subpopulation of patients with symptomatic a…

2018
doi:10.3389/fneur.2018.00135 ·PMID:29615953

Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord. The inflammasome is a multiprotein complex that contributes to the innate immune response in animal models of MS as well as in patients with the diseas…

2016
doi:10.3389/fneur.2016.00143 ·PMID:27625632

The endocrine disruptors (EDs) are able to influence the endocrine system, mimicking or antagonizing hormonal molecules. They are bio-persistent for their degradation resistance in the environment. Our research group has investigated by gas…